• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Rabbit Polyclonal to SLC25A12

Gain of functional mutations in occurs in a lot more than

December 16, 2018 by Katherine Lewis Leave a Comment

Gain of functional mutations in occurs in a lot more than 30% of human being malignancies and specifically 90% of pancreatic tumor. persistent oncogenic tension and following apoptotic problems. [11, 12]. Furthermore, research (including ours) shown that lack of PKC (specifically the phorbol ester-dependent subgroup of PKC isoforms), as well as Ras mutations, had been … [Read more…]

Posted in: Blogging Tagged: BIBR-1048, Rabbit Polyclonal to SLC25A12

Background The spatiotemporal regulation of gene expression mainly depends upon the

August 15, 2017 by Katherine Lewis Leave a Comment

Background The spatiotemporal regulation of gene expression mainly depends upon the absence and presence of cis-regulatory sites in the promoter. function in the rules of transcript amounts in grain and, also in sorghum presumably. Conclusion Our function provides the 1st large-scale assortment of cis-components for grain and sorghum and may provide as a paradigm for … [Read more…]

Posted in: Blogging Tagged: 616-91-1, Rabbit Polyclonal to SLC25A12

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by